Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
482
2.610
 Why?
Thrombolytic Therapy
4
2022
110
1.290
 Why?
Pneumonia, Viral
6
2020
169
1.280
 Why?
Fibrinolytic Agents
4
2022
125
1.280
 Why?
Coronavirus Infections
6
2020
178
1.260
 Why?
Tissue Plasminogen Activator
3
2020
110
1.240
 Why?
Pandemics
8
2020
567
0.830
 Why?
Endovascular Procedures
2
2022
176
0.830
 Why?
Cavernous Sinus
1
2022
15
0.790
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
11
0.790
 Why?
Conflict of Interest
2
2020
25
0.730
 Why?
Embolization, Therapeutic
1
2022
86
0.730
 Why?
Iodine Compounds
1
2020
7
0.710
 Why?
Brain Edema
1
2020
41
0.690
 Why?
Brain Ischemia
4
2022
158
0.650
 Why?
Cardiology
1
2020
87
0.640
 Why?
Mucopolysaccharidosis II
1
2018
1
0.640
 Why?
Contrast Media
1
2020
186
0.640
 Why?
Medicare
1
2020
248
0.620
 Why?
Coronary Angiography
1
2020
355
0.620
 Why?
Physicians
1
2020
227
0.560
 Why?
Hospitalization
6
2022
663
0.490
 Why?
Databases, Factual
3
2020
655
0.420
 Why?
Telemedicine
1
2019
459
0.420
 Why?
Humans
29
2022
50251
0.410
 Why?
Headache
2
2022
76
0.370
 Why?
Aged
10
2021
9427
0.370
 Why?
Time Factors
4
2020
2911
0.350
 Why?
Autoimmune Diseases
2
2020
101
0.340
 Why?
Ischemic Attack, Transient
2
2020
56
0.330
 Why?
Immunosuppressive Agents
2
2020
223
0.320
 Why?
United States
6
2020
4887
0.300
 Why?
Female
16
2021
26668
0.290
 Why?
Male
14
2021
25483
0.270
 Why?
Arkansas
4
2019
1962
0.270
 Why?
Emergency Service, Hospital
2
2020
483
0.250
 Why?
Middle Aged
11
2021
12234
0.250
 Why?
Tomography, X-Ray Computed
2
2020
1169
0.230
 Why?
Triage
2
2021
63
0.230
 Why?
Thrombectomy
2
2020
68
0.220
 Why?
Drug Industry
2
2020
38
0.220
 Why?
Neuroimaging
2
2020
85
0.210
 Why?
Critical Care
2
2021
213
0.200
 Why?
Retrospective Studies
5
2020
6172
0.200
 Why?
Sinus Thrombosis, Intracranial
1
2021
17
0.190
 Why?
Myasthenia Gravis
1
2021
17
0.190
 Why?
Hospitalists
1
2020
11
0.190
 Why?
Intracranial Thrombosis
1
2020
16
0.180
 Why?
Ageusia
1
2020
6
0.180
 Why?
Olfaction Disorders
1
2020
7
0.180
 Why?
Neuromuscular Diseases
1
2020
30
0.180
 Why?
Osmolar Concentration
1
2020
63
0.180
 Why?
Health Services Misuse
1
2020
13
0.180
 Why?
Lymphoma, Non-Hodgkin
1
2020
59
0.180
 Why?
Multiple Sclerosis
1
2020
65
0.180
 Why?
Health Care Sector
1
2020
15
0.180
 Why?
Neurologic Examination
1
2020
77
0.170
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.170
 Why?
Mood Disorders
1
2020
58
0.170
 Why?
Time-to-Treatment
1
2020
69
0.170
 Why?
Patient Transfer
1
2020
94
0.170
 Why?
Young Adult
2
2020
4002
0.170
 Why?
Brain Diseases
1
2020
81
0.170
 Why?
Venous Thrombosis
1
2020
90
0.170
 Why?
Subarachnoid Hemorrhage
1
2020
62
0.170
 Why?
Drug-Eluting Stents
1
2020
93
0.170
 Why?
Suicidal Ideation
1
2020
98
0.170
 Why?
Fabry Disease
1
2019
9
0.170
 Why?
Enzyme Replacement Therapy
1
2019
17
0.170
 Why?
Recombinant Fusion Proteins
1
2010
187
0.160
 Why?
Hospitals
1
2020
173
0.160
 Why?
Fluorocarbons
1
2019
46
0.160
 Why?
Nervous System Diseases
1
2020
89
0.160
 Why?
Tomography Scanners, X-Ray Computed
1
2018
12
0.160
 Why?
Aged, 80 and over
3
2020
3140
0.160
 Why?
Angiogenesis Inhibitors
1
2010
188
0.160
 Why?
Angiography, Digital Subtraction
1
2018
27
0.160
 Why?
Neuroprotective Agents
1
2019
104
0.160
 Why?
Seizures
1
2020
197
0.150
 Why?
Anxiety
1
2020
277
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
131
0.150
 Why?
Pain
1
2020
380
0.150
 Why?
Meningitis
1
2016
25
0.140
 Why?
Referral and Consultation
1
2019
285
0.140
 Why?
Diagnosis, Differential
1
2020
1043
0.140
 Why?
Myocardial Infarction
1
2020
389
0.130
 Why?
Antibodies, Monoclonal
1
2010
461
0.130
 Why?
Percutaneous Coronary Intervention
1
2020
301
0.130
 Why?
Ovarian Neoplasms
1
2010
448
0.130
 Why?
Plasma Cells
1
2016
223
0.130
 Why?
Magnetic Resonance Imaging
2
2020
1542
0.120
 Why?
Adult
5
2020
13384
0.120
 Why?
RNA-Directed DNA Polymerase
1
2002
6
0.110
 Why?
Oligodeoxyribonucleotides
1
2002
29
0.100
 Why?
DNA, Complementary
1
2002
135
0.100
 Why?
Adolescent
2
2020
6402
0.100
 Why?
Antineoplastic Agents
1
2010
1186
0.100
 Why?
Mycobacterium tuberculosis
1
2002
286
0.090
 Why?
Treatment Outcome
4
2022
5186
0.090
 Why?
Intubation, Intratracheal
2
2021
118
0.080
 Why?
Cohort Studies
2
2022
1397
0.070
 Why?
Prevalence
2
2020
953
0.070
 Why?
Risk Factors
2
2022
3608
0.050
 Why?
Intracranial Hemorrhages
1
2022
37
0.050
 Why?
Multiple Myeloma
1
2016
2958
0.050
 Why?
Cerebral Hemorrhage
1
2022
99
0.050
 Why?
Cranial Sinuses
1
2021
10
0.050
 Why?
Industry
1
2020
17
0.050
 Why?
Arthritis, Psoriatic
1
2020
9
0.050
 Why?
Spondylitis, Ankylosing
1
2020
9
0.050
 Why?
Cranial Nerves
1
2020
14
0.050
 Why?
Disease Susceptibility
1
2021
88
0.050
 Why?
Endocrine System Diseases
1
2010
10
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
 Why?
Colitis, Ulcerative
1
2020
51
0.040
 Why?
Mortality
1
2020
100
0.040
 Why?
Arthritis, Rheumatoid
1
2020
105
0.040
 Why?
Registries
1
2022
513
0.040
 Why?
Crohn Disease
1
2020
92
0.040
 Why?
Maximum Tolerated Dose
1
2019
38
0.040
 Why?
Administration, Oral
1
2020
435
0.040
 Why?
Tertiary Care Centers
1
2019
77
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Disease Outbreaks
1
2020
123
0.040
 Why?
Administration, Intravenous
1
2019
69
0.040
 Why?
Disability Evaluation
1
2019
87
0.040
 Why?
Hemorrhage
1
2020
197
0.040
 Why?
Skin Diseases
1
2010
111
0.040
 Why?
Gastrointestinal Diseases
1
2010
126
0.040
 Why?
Electronic Health Records
1
2021
212
0.040
 Why?
Drug Administration Schedule
1
2019
374
0.040
 Why?
Recovery of Function
1
2019
188
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
225
0.040
 Why?
Comorbidity
1
2019
606
0.040
 Why?
Patient Readmission
1
2019
218
0.040
 Why?
Double-Blind Method
1
2019
683
0.040
 Why?
Prognosis
1
2022
1959
0.040
 Why?
Fatal Outcome
1
2016
196
0.030
 Why?
Follow-Up Studies
1
2020
2180
0.030
 Why?
Risk Assessment
1
2019
1257
0.030
 Why?
Cardiovascular Diseases
1
2010
442
0.030
 Why?
Prospective Studies
1
2020
2379
0.030
 Why?
Cross-Sectional Studies
1
2019
1557
0.030
 Why?
DNA Primers
1
2002
207
0.030
 Why?
Infant
1
2020
3560
0.020
 Why?
Child, Preschool
1
2020
3877
0.020
 Why?
Transcription, Genetic
1
2002
370
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
412
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
191
0.020
 Why?
RNA, Messenger
1
2002
1108
0.020
 Why?
Child
1
2020
6854
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (151) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department